Skip to content

Opinion

Better organization would lift NACDS Marketplace

The National Association of Chain Drug Stores, it has been said, makes friends in the spring and enemies in early summer, repairs relationships in late summer and then solidifies relationships during the winter. Well, it’s early summer. The NACDS Marketplace Conference has just ended.

NACDS Annual Meeting a major triumph

Over three very special days at the end of April, the National Association of Chain Drug Stores staged one of the memorable retailing conventions of recent times, a thrilling and productive spectacle that brought together the leading retailers and suppliers in America and gave them both the stage an

Suydam shows how to run a trade group

Linda Suydam, president of the Consumer Healthcare Products Association, will retire by year’s end after eight years as head of the proprietary medicines organization. At the association’s annual meeting last month in Aventura, Fla.

Chain, independent Rx exhibit spirit of unity

A recent edition of The New York Times carried a story about the plight of independent pharmacies in America. Appearing under the headline, “For a Drugstore, ‘Nice’ Isn’t a Panacea,” the article does a good job outlining the strengths of independents and the challenges that they currently face.

Walgreens reenergized under Wasson

To those who have come to know and admire Greg Wasson, the just-announced Walgreens acquisition of Duane Reade comes as no surprise. Indeed, in the year that has passed since Wasson was named chief executive officer of the Walgreen Co., he has thrown off surprises and excitement like a pinwheel.

Rx should prepare for a long haul

The political landscape that retail pharmacy advocates will have to traverse has grown considerably more complex in recent weeks with the surprising victory of Republican Scott Brown in the race for the Senate seat that had been held by Edward Kennedy, the Massachusetts Democrat, for 47 years, and t

Regional chains can still make an impact

The sale of most of the assets of Snyders Drug Stores to Walgreens and the planned closure of the balance of the corporately owned outlets in the chain once again brings to the fore the difficulties regional operators confront in an era when the community pharmacy business is national in scope and a